A deal has been struck to let the NHS offer children an expensive new cancer therapy that has been called the most exciting treatment advance for decades

Dr Alice Giustacchini, University College London and John Goldman Fellow

After eight successful years with us, Angela Smith-Morgan will be stepping down from her role as Co CEO of Leukaemia UK on 3rd September.

A former nurse, midwife, health visitor and NHS manager is welcoming new research into her particular blood cancer, after not recognising her mystery symptoms were leukaemia.  Kay Cutting, from Seaham…